Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Mobic

Aliases
Mobic® 15 mg Tablets, Mobic® Tablets 15 mg

3 clinical trials

1 indication

Indication
Healthy
Clinical trial
Single-Dose Fasting In Vivo Bioequivalence Study of Meloxicam Tablets (15 mg; Mylan) and Mobic® Tablets (15 mg; Boehringer Ingelheim) in Healthy Volunteers
Status: Completed, Estimated PCD: 2004-09-01
Clinical trial
Single-Dose Food In Vivo Bioequivalence Study of Meloxicam Tablets (15 mg; Mylan) and Mobic® Tablets (15 mg; Boehringer Ingelheim) in Healthy Volunteers
Status: Completed, Estimated PCD: 2004-09-01
Clinical trial
A Two-way Crossover, Open-label, Single-dose, Fasting, Bioequivalence Study of Meloxicam 15 mg Tablets Versus Mobic® 15 mg Tablets in Normal Healthy Non-Smoking Male and Female Subjects
Status: Completed, Estimated PCD: 2004-02-01